Axlata Coating Systems Ltd. plans to close its Center City global headquarters office and move out of the 36,000 square feet it has occupied at Two Commerce Square for the last seven years.

Employees working out of Philadelphia will relocate to either its 55,000-square-foot North American headquarters off Applied Bank Way in Glen Mills or its 175,000-square-foot research facility at the Philadelphia Navy Yard.

The decision to close its Center City office comes after the company went through a restructuring over the summer that led it to realign its real estate and other operations. The restructuring will result in 550 job cuts over the next two years as part of plan to generate $50 million in savings amid economic pressures.

The move out of Center City veers from Axalta’s (NYSE: AXTA) original plans when it spun out of DuPont Inc. in 2013 and moved out of Delaware and deliberately split its global and North American headquarters into two locations.

The company said at the time it wanted to have a distinct location for its global and North American headquarters.The company then decided to place its global headquarters in Commerce Square, saying at the time it preferred an urban setting near mass transit as well as the Philadelphia International Airport. The company then moved its North American headquarters to Glen Mills, contending it was closer to where most employees, who had previously worked at DuPont, live and from where they had been commuting for years.

In that time, the company, which makes coatings that go into paint used on vehicles and other products, went from being privately owned to publicly traded.

Axalta announced in late March that it ended a review of strategic alternatives it began in 2019 to explore a potential sale of the company, saying the impact of the coronavirus on markets was to blame.

Philadelphia office shifts will be completed in mid-2021.

*Article Courtesy of Philadelphia Business Journal

For more information about Philadelphia office space for sale or lease in Philadelphia or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  Philadelphia commercial real estate broker that provides a full range of Philadelphia commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other Philadelphia commercial properties for buyers, tenants, investors and sellers.

Please visit our websites for a full listing of Philadelphia commercial properties for lease or sale through our Philadelphia commercial real estate brokerage firm.

As many as 85% of tenants in one office landlord’s buildings across the country are still working from home, and its executives say large employers are realizing they may have more of a struggle on their hands in getting everyone back than first anticipated.

Brandywine Realty Trust executives are finding that even as some tenant employees are growing annoyed with full-time remote working, the big companies have a laundry list of concerns that they are finding that they can’t manage away.

“The longer this has gone on, the more we are hearing consistently across our office base that they can’t wait to return to the office,” said Jerry Sweeney, CEO of the real estate investment trust, during a conference call to discuss its most recent earnings. However, public policy, mass transit and concerns about liability for employers are holding many companies back, particularly larger firms such as Comcast and Lincoln Financial in Philadelphia, he said.

Seven months into the pandemic in the United States, office landlords with buildings spread across different regions of the country are providing an across-the-board glimpse into the way tenant companies are dealing with having their workers outside the office. As new confirmed coronavirus cases reach daily records around the country, more top executives are facing talking with their landlords about the worsening conditions that are forcing them to write rent checks for buildings they mostly aren’t filling up right now.

Brandywine, which owns about 15 million square feet of space located mostly across Philadelphia, Washington, Virginia and Austin, Texas, reported that just 15% of its U.S. office tenant base has returned to the office. But that percentage is noticeably lower in Austin, where it is one of the city’s biggest office landlords.

Only 8% of Brandywine’s office tenant base in Austin has returned to work in person at the office a full seven months after the pandemic started, according to the office REIT. That percentage is being held down because one of its major office tenants in Austin, IBM, doesn’t plan to send its employees back to its north Austin campus until early next year, Sweeney said.

Without IBM, Brandywine’s Austin’s percentage of office tenants back at the office would be somewhere in the “mid-teens,” Sweeney said. Across its portfolio, the Washington area is seeing the highest percentage of tenants going back to the office at 25%.

Construction on the 25-story 405 Colorado in downtown Austin is expected to be complete early next year. (Brandywine).

Public health guidelines in cities like Philadelphia, where Brandywine is based, are still requiring employees to work remotely when feasible, though Sweeney said about 18% of its tenant base in Philadelphia’s suburbs are back at the office.

Meanwhile, Texas health officials are also encouraging remote work when possible, though the governor has allowed offices to operate at 75% capacity since September.

“Austin, I think, wound up being one of those cities that had opened up early then had some surge issues reduced or retracted back some of that progress and now is on the way back,” Sweeney said.

Even with 85% of its office tenant base mostly still working remotely, tenants are still paying rent. Brandywine collected 99% of its expected office rental income in the third quarter and 97% of its expected rental income in October so far, Sweeney said

Building projects are still moving forward. Brandywine is on track to complete construction of its $116 million office tower in downtown Austin called 405 Colorado early next year. DLA Piper law firm backed out of a lease in the project earlier this year, leaving the tower now just 18.3% preleased months away from delivery. However, Sweeney said there is nearly 200,000 square feet of potential deals in the leasing pipeline for 405 Colorado.

Elsewhere in Austin, Brandywine expects to receive final approvals from the city of Austin for Block A within its broader redevelopment of the 66-acre Broadmoor campus, where IBM is located not far from The Domain, the company said. Block A is expected to consist of a 350,000-square-foot office building and 340 apartments. Overall, the Broadmoor plan calls for a massive mixed-use hub with up to 3.2 million square feet of office space, 2.9 million square feet of residential space, 382,000 square feet of retail space and 284,000 square feet of hotel space.

Brandywine is continuing to develop Schuylkill Yards in Philadelphia with a new life sciences focus. (Brandywine)

In the Philadelphia area, its major development project in the works is Schuylkill Yards, a multiphase, 5.1 million-square-foot mixed-use development. Brandywine completed construction of the Bulletin building there in the second quarter, and it has acquired the leasehold land to develop two mixed-use buildings totaling 1.3 million square feet at 3025 JFK and 3001 JFK, according to its latest earnings update.

Also in Philadelphia in July, Brandywine sold its 30% equity stake in One and Two Commerce Square to an institutional investor for $115 million.

In the Arlington, Virginia, area outside D.C., Brandywine expects to complete construction on a $224 million mixed-use tower, 4040 Wilson, in the first quarter through a joint venture with Shooshan Co. The 22-story building is 62% preleased.

Overall, Brandywine saw its net income spike to $274 million in the third quarter from $6.7 million during the same time last year because of significantly less expenses, but its revenue in the third quarter fell 13% to $126 million compared to $145 million for the quarter last year.

*Article Courtesy of CoStar

For more information about Philadelphia office space for sale or lease in Philadelphia or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  Philadelphia commercial real estate broker that provides a full range of Philadelphia commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other Philadelphia commercial properties for buyers, tenants, investors and sellers.

Please visit our websites for a full listing of Philadelphia commercial properties for lease or sale through our Philadelphia commercial real estate brokerage firm.

Imvax expected to host an event in April or May to unveil its new headquarters at The Curtis in the Old City section of Philadelphia, but the ongoing pandemic scuttled those plans.

“Covid-19 clearly got in the way,” said John Furey, the former Spark Therapeutics executive who was hired as CEO of Imvax last year. “Once we see the light at the end of the tunnel with all of this, we’ll do something” to show off the new space.

The company previously operated out of a small office in Chestnut Hill and took the 17,000 square feet of space at the iconic Curtis building to keep up with its expansion.

Imvax currently has a staff of 18 and expects to get to 25 by year’s end, Furey said, adding he expects that figure to double in 2021.

“We are in a rapid expansion mode,” he said.

Imvax was founded in 2015 Dr. David Andrews, a Thomas Jefferson University Hospital neurosurgeon; Craig Hooper, a professor in the department of cancer biology at Jefferson; Pete Corr, a former Pfizer executive; and journalist-turned-entrepreneur Arthur W. Howe IV.

The company has raised $152 million from investors since its inception.

Andrews, the company’s chief medical officer, has spent the past two decades leading a team of researchers and clinicians at Thomas Jefferson University working on an immunotherapy treatment for a rare and lethal type of brain cancer known as glioblastoma multiforme.

The treatment involves creating a tumor vaccine made from patients’ tumor cells, and combining it with what is known as an antisense molecule. The combination produces a personalized immune response that works in conjunction with the standard treatment for glioblastoma: surgery, chemotherapy and radiation.

Imvax posted positive interim results from early-stage testing that showed the vaccine, IGV-001, outperformed the standard of care treatment and produced prolonged overall survival and progression-free survival in patients with newly diagnosed glioblastoma multiforme.

Furey said the company expects to begin a mid-stage clinical trial of IGV-001 in newly diagnosed glioblastoma patients by the middle of next year. Imvax has an exclusive license agreement with Thomas Jefferson University granting it the right to develop and market the medical technology.

Furey said he was recruited to Imvax by Dr. Steven Altschuler, who was CEO of Children’s Hospital of Philadelphia when it spun out Spark Therapeutics in 2013. Altschuler is managing director for health care ventures at Ziff Capital Partners, one of Imvax’s investors.

This year, Imvax added Mark Exley as its chief scientific officer. He was previously vice president of cellular Immunology at AgenTus Therapeutics in Lexington, Massachusetts. Another new hire is Iphigenia Leonidou Koumenis, who joined ImVax as head of clinical operations in June. She was previously senior vice president of clinical operations at Wilmington-based Orsenix Inc.

Furey said the company will be adding staff in all areas including drug development, clinical operations and manufacturing. Imvax is finalizing plans to take another 3,000 square feet of adjacent space at The Curtis to expand its manufacturing capabilities at the site, he said.

The Curtis is located at 601 Walnut St. and owned by Keystone Property Group. The site once served as the headquarters for Curtis Publishing Co. and was where the Saturday Evening Post and a variety of other magazines were printed.

Key building features— such as reinforced floors that once supported larger printing presses, high ceilings and a structural design that allows venting to the roof — made it an ideal choice for an immunotherapy company conducting drug development research.

Scheer Partners, the specialty scientific real estate firm that recently opened a Philadelphia office, has a representation agreement with Keystone Property Group for The Curtis and is marketing the site to other life sciences companies. Robert Scheer said his firm is in negotiations with several prospective life sciences tenants, and expects to soon sign leases totaling upwards of 100,000 square feet of space in the building.

Imvax will act as an example when luring other biotech firms to the building, Scheer said.

Added Furey: “I wonder if Mr. Curtis could have imagined his building would be repurposed for this kind of next-generation technology.”

*Article Courtesy of Philadelphia Business Journal

For more information about Philadelphia office space for sale or lease in Philadelphia or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  Philadelphia commercial real estate broker that provides a full range of Philadelphia commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other Philadelphia commercial properties for buyers, tenants, investors and sellers.

Please visit our websites for a full listing of Philadelphia commercial properties for lease or sale through our Philadelphia commercial real estate brokerage firm.

Rubenstein Partners is moving forward with a $50 million repositioning of Chesterbrook, which is what the real estate company is now calling and branding the Tredyffrin business park it bought in the summer of 2019.

The Philadelphia real estate company has five of the 14 buildings totaling 1.1 million square feet it bought under some stage of construction and expects to soon begin work on another three buildings. Interior renovations will include upgrades to lobbies and common areas as well as HVAC systems and incorporating more touchless technology. Exterior renovations will involve improving facades of several entrances. A parking deck will also be built on a lot between 725 and 735 Chesterbrook Blvd.

“We’re pushing ahead full steam here,” said Lou Merlini, vice president of asset management at Rubenstein, which paid $148.5 million for the decades-old office park. “When the market gets uncertain, some people pull back on their plans. We believe in having the best product coming out of a period of uncertainty.”

Rubenstein has built its business strategy on acquiring office properties that need some interior or exterior work, or sometimes both, and many of the buildings it buys often have some vacancies that need to be backfilled.

In spite of companies not populating their offices with employees during the pandemic, many businesses are reevaluating their need for office space or the amount of square feet they currently have, leaving Rubenstein confident in the future of office space. It believes there will be a flight to quality post pandemic, which is what it experienced after the Great Recession.

When it comes to Chesterbrook, Rubenstein spent the last year completing local approvals and the design of the campus-wide transformation it has started to undertake. As it has with other properties it has purchased, Rubenstein not only looks at how it can physically change the real estate but also how to brand it.

In this case, what had been known as the Chesterbrook Corporate Center will now simply be Chesterbrook. The shorter, succinct name reflects the “overall vibe” of what Rubenstein is attempting to establish at Chesterbrook.

“We want to create a modern campus with a sense of place,” Merlini said. “Chesterbrook Corporate Center, over time, became buildings on parking lots. We want to have the buildings more integrated.”

The centerpiece to Rubenstein’s plans at Chesterbrook is converting a vacant, two-story, 40,000-square-foot building at 851 DuPortail Road into an amenity hub. The building will be totally renovated and reimagined. The first floor will have food, fitness and conference space and the upper floor flexible office space. The outside will have a variety of seating areas. It will be called “Circuit.”

“The idea is that every tenant in the park can feel tied back to this building,” Merlini said.

The last piece of the puzzle involves connecting the buildings with other elements in the park. To that end, new pathways will connect to existing trails and Wilson Farm Park, bicycle stations established and a shuttle service started. In addition, new signs and wayfinding will be incorporated throughout the campus.

The bulk of the work to the buildings is expected to be completed during the first half of next year and the amenity center is anticipated to be done by the end of next year.

When Rubenstein bought Chesterbrook, it was 80% occupied and the occupancy is expected to fall even more next year when AmerisourceBergen Corp. vacates 200,000 square feet and relocates to a new headquarters in Conshohocken.

The Philadelphia real estate company has chipped away at that vacancy. Over the summer, BNP Paribas leased 59,000 square feet at 735 Chesterbrook Blvd. The 84,000-square-foot building had once been occupied by Shire Pharmaceuticals, which it vacated along with 725 Chesterbrook Blvd. BNP will relocate out of 14,000 square feet at 555 Croton Road in King of Prussia.

*Article Courtesy of Philadelphia Business Journal

For more information about Philadelphia office space for sale or lease in Philadelphia or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  Philadelphia commercial real estate broker that provides a full range of Philadelphia commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other Philadelphia commercial properties for buyers, tenants, investors and sellers.

Please visit our websites for a full listing of Philadelphia commercial properties for lease or sale through our Philadelphia commercial real estate brokerage firm.

It’s with little frequency Philadelphia experiences a ground breaking for a new office building let alone one in the middle of global pandemic but, in a city of firsts, that is what took place Monday morning along the western edge of the Central Business District.

Construction began for 2222 Market St., a $200 million office tower that will house the headquarters of law firm Morgan Lewis & Bockius. Last December, Morgan Lewis signed a 20-year lease for the development of what will be a 19-story, 305,000-square-foot building that the law firm will fully occupy.

The project is forward-looking. It looks to a future when companies and employees can safely return to their offices. It confirms the law firm’s commitment to its own future, and it’s a recognition of Philadelphia’s future.

The building will stand as a monument to Philadelphia’s spirit and confidence in what’s to come, said Sarah E. Bouchard, managing partner at Morgan Lewis’ Philadelphia office.

*Article Courtesy of Philadelphia Business Journal

For more information about Philadelphia office space for sale or lease in Philadelphia or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  Philadelphia commercial real estate broker that provides a full range of Philadelphia commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other Philadelphia commercial properties for buyers, tenants, investors and sellers.

Please visit our websites for a full listing of Philadelphia commercial properties for lease or sale through our  Philadelphia commercial real estate brokerage firm.